 Charles Snyder
Concepts (631)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Appendicitis | 20 | 2022 | 118 | 4.410 |
Why?
| | Appendectomy | 15 | 2022 | 103 | 2.700 |
Why?
| | Humans | 152 | 2024 | 6915 | 2.700 |
Why?
| | Male | 97 | 2024 | 3383 | 2.230 |
Why?
| | Retrospective Studies | 73 | 2023 | 1300 | 2.120 |
Why?
| | Female | 89 | 2024 | 3563 | 2.000 |
Why?
| | Laparoscopy | 23 | 2022 | 209 | 1.910 |
Why?
| | Child | 80 | 2023 | 3393 | 1.870 |
Why?
| | Pediatrics | 8 | 2016 | 185 | 1.750 |
Why?
| | Funnel Chest | 14 | 2022 | 56 | 1.550 |
Why?
| | Infant, Newborn | 43 | 2021 | 825 | 1.490 |
Why?
| | Treatment Outcome | 36 | 2023 | 624 | 1.340 |
Why?
| | Adolescent | 51 | 2023 | 2235 | 1.300 |
Why?
| | Postoperative Complications | 20 | 2023 | 187 | 1.230 |
Why?
| | Intestinal Obstruction | 5 | 2012 | 19 | 1.210 |
Why?
| | Infant | 42 | 2023 | 1464 | 1.150 |
Why?
| | Child, Preschool | 43 | 2020 | 1600 | 1.130 |
Why?
| | Tracheoesophageal Fistula | 10 | 2006 | 28 | 1.100 |
Why?
| | Hernia, Inguinal | 5 | 2021 | 29 | 1.100 |
Why?
| | Esophageal Atresia | 11 | 2008 | 33 | 1.040 |
Why?
| | Enterocolitis, Necrotizing | 5 | 2013 | 67 | 1.020 |
Why?
| | Intestinal Atresia | 5 | 2023 | 16 | 0.990 |
Why?
| | Gastroesophageal Reflux | 6 | 2016 | 41 | 0.960 |
Why?
| | Catheterization | 6 | 2016 | 28 | 0.900 |
Why?
| | Abnormalities, Multiple | 6 | 2009 | 36 | 0.800 |
Why?
| | General Surgery | 5 | 2013 | 19 | 0.790 |
Why?
| | Cryptorchidism | 3 | 2016 | 16 | 0.780 |
Why?
| | Pyloric Stenosis | 4 | 2016 | 10 | 0.770 |
Why?
| | Duodenal Obstruction | 5 | 2023 | 14 | 0.760 |
Why?
| | Meckel Diverticulum | 2 | 2014 | 7 | 0.750 |
Why?
| | Hirschsprung Disease | 4 | 2021 | 54 | 0.730 |
Why?
| | Gallbladder Diseases | 3 | 2016 | 12 | 0.720 |
Why?
| | Digestive System Surgical Procedures | 4 | 2011 | 38 | 0.710 |
Why?
| | Length of Stay | 20 | 2023 | 239 | 0.690 |
Why?
| | Incidence | 10 | 2014 | 134 | 0.690 |
Why?
| | Anti-Bacterial Agents | 10 | 2022 | 251 | 0.670 |
Why?
| | Tourniquets | 1 | 2019 | 1 | 0.660 |
Why?
| | Emergencies | 1 | 2019 | 11 | 0.660 |
Why?
| | Extracorporeal Membrane Oxygenation | 4 | 2016 | 16 | 0.640 |
Why?
| | Gastroschisis | 3 | 2005 | 23 | 0.610 |
Why?
| | Minimally Invasive Surgical Procedures | 8 | 2022 | 38 | 0.610 |
Why?
| | Congenital Abnormalities | 3 | 2016 | 17 | 0.610 |
Why?
| | Laparotomy | 4 | 2012 | 21 | 0.600 |
Why?
| | Opioid-Related Disorders | 1 | 2017 | 15 | 0.590 |
Why?
| | Analgesics, Opioid | 1 | 2017 | 43 | 0.580 |
Why?
| | Esophagus | 6 | 2013 | 29 | 0.570 |
Why?
| | Follow-Up Studies | 20 | 2020 | 302 | 0.560 |
Why?
| | Adult | 17 | 2024 | 1187 | 0.550 |
Why?
| | Diagnostic Imaging | 1 | 2016 | 16 | 0.550 |
Why?
| | Internship and Residency | 3 | 2013 | 39 | 0.540 |
Why?
| | Gastrostomy | 6 | 2022 | 62 | 0.540 |
Why?
| | Bone Morphogenetic Proteins | 2 | 2006 | 7 | 0.530 |
Why?
| | Wounds, Nonpenetrating | 5 | 2023 | 57 | 0.510 |
Why?
| | Duodenum | 2 | 2020 | 21 | 0.480 |
Why?
| | Hernia, Umbilical | 2 | 2021 | 14 | 0.470 |
Why?
| | Severity of Illness Index | 3 | 2011 | 153 | 0.470 |
Why?
| | Soft Tissue Neoplasms | 2 | 2011 | 6 | 0.470 |
Why?
| | Acute Disease | 3 | 2022 | 82 | 0.470 |
Why?
| | Neutropenia | 2 | 2011 | 12 | 0.470 |
Why?
| | Hospitals, Pediatric | 6 | 2017 | 188 | 0.460 |
Why?
| | Fundoplication | 5 | 2010 | 35 | 0.450 |
Why?
| | Intestinal Perforation | 1 | 2013 | 11 | 0.440 |
Why?
| | Ileal Diseases | 1 | 2013 | 7 | 0.440 |
Why?
| | United States | 7 | 2020 | 685 | 0.440 |
Why?
| | Fraud | 1 | 2013 | 2 | 0.440 |
Why?
| | Algorithms | 2 | 2011 | 103 | 0.440 |
Why?
| | Surgical Wound Infection | 5 | 2021 | 45 | 0.440 |
Why?
| | Publishing | 1 | 2013 | 8 | 0.440 |
Why?
| | Authorship | 1 | 2013 | 3 | 0.440 |
Why?
| | Pneumothorax | 4 | 2023 | 30 | 0.430 |
Why?
| | Fellowships and Scholarships | 1 | 2013 | 17 | 0.430 |
Why?
| | Risk Factors | 10 | 2016 | 485 | 0.430 |
Why?
| | Spleen | 4 | 2023 | 30 | 0.430 |
Why?
| | Digestive System Abnormalities | 2 | 2012 | 6 | 0.420 |
Why?
| | Heart Defects, Congenital | 5 | 2008 | 80 | 0.420 |
Why?
| | Tomography, X-Ray Computed | 7 | 2011 | 117 | 0.410 |
Why?
| | Signal Transduction | 6 | 2006 | 115 | 0.410 |
Why?
| | Pyloric Stenosis, Hypertrophic | 2 | 2023 | 21 | 0.400 |
Why?
| | Foreign Bodies | 3 | 2013 | 23 | 0.400 |
Why?
| | Prospective Studies | 17 | 2020 | 532 | 0.400 |
Why?
| | Cholecystectomy, Laparoscopic | 4 | 2021 | 25 | 0.390 |
Why?
| | Rectum | 2 | 2010 | 27 | 0.390 |
Why?
| | Mediastinal Neoplasms | 1 | 2011 | 5 | 0.390 |
Why?
| | Orthopedic Procedures | 3 | 2017 | 14 | 0.380 |
Why?
| | Personnel Selection | 1 | 2011 | 3 | 0.380 |
Why?
| | Surgical Mesh | 2 | 2010 | 8 | 0.380 |
Why?
| | Databases, Factual | 5 | 2016 | 109 | 0.380 |
Why?
| | Airway Obstruction | 1 | 2011 | 20 | 0.380 |
Why?
| | Thoracotomy | 6 | 2023 | 18 | 0.380 |
Why?
| | Fibrosarcoma | 1 | 2011 | 1 | 0.380 |
Why?
| | Specialties, Surgical | 1 | 2011 | 14 | 0.370 |
Why?
| | Penis | 2 | 2009 | 5 | 0.370 |
Why?
| | Colitis | 1 | 2011 | 12 | 0.370 |
Why?
| | Cryosurgery | 2 | 2022 | 11 | 0.370 |
Why?
| | Esophagoscopy | 3 | 2010 | 11 | 0.370 |
Why?
| | Periodicity | 1 | 2010 | 2 | 0.360 |
Why?
| | Antineoplastic Agents | 1 | 2011 | 55 | 0.360 |
Why?
| | Rectal Prolapse | 1 | 2010 | 9 | 0.360 |
Why?
| | Enterocolitis | 2 | 2021 | 35 | 0.360 |
Why?
| | Abdominal Neoplasms | 1 | 2010 | 5 | 0.350 |
Why?
| | Gynecomastia | 1 | 2010 | 2 | 0.350 |
Why?
| | Mastectomy, Subcutaneous | 1 | 2010 | 3 | 0.350 |
Why?
| | Mammaplasty | 1 | 2010 | 3 | 0.350 |
Why?
| | Abdomen | 2 | 2022 | 12 | 0.340 |
Why?
| | Pain, Postoperative | 4 | 2022 | 36 | 0.330 |
Why?
| | Urachus | 2 | 2007 | 3 | 0.330 |
Why?
| | Surgical Procedures, Operative | 3 | 2006 | 15 | 0.320 |
Why?
| | Braces | 2 | 2019 | 8 | 0.310 |
Why?
| | Pectus Carinatum | 2 | 2019 | 8 | 0.310 |
Why?
| | Risk Assessment | 3 | 2022 | 136 | 0.310 |
Why?
| | Hernia, Diaphragmatic | 2 | 2010 | 13 | 0.310 |
Why?
| | Meconium | 1 | 2008 | 3 | 0.310 |
Why?
| | Hernias, Diaphragmatic, Congenital | 2 | 2010 | 17 | 0.310 |
Why?
| | Abdominal Injuries | 3 | 2023 | 27 | 0.310 |
Why?
| | Umbilicus | 2 | 2011 | 8 | 0.310 |
Why?
| | Delivery, Obstetric | 2 | 2005 | 5 | 0.300 |
Why?
| | Down Syndrome | 1 | 2008 | 39 | 0.300 |
Why?
| | Prognosis | 8 | 2013 | 212 | 0.290 |
Why?
| | Infant, Newborn, Diseases | 1 | 2008 | 30 | 0.290 |
Why?
| | Patient Readmission | 3 | 2017 | 69 | 0.290 |
Why?
| | Hypospadias | 2 | 2005 | 4 | 0.290 |
Why?
| | Vitelline Duct | 1 | 2007 | 1 | 0.280 |
Why?
| | Mullerian Ducts | 1 | 2006 | 3 | 0.280 |
Why?
| | Uterus | 1 | 2006 | 10 | 0.280 |
Why?
| | Abdominal Abscess | 3 | 2012 | 25 | 0.270 |
Why?
| | Analgesia, Epidural | 2 | 2019 | 9 | 0.270 |
Why?
| | Recurrence | 9 | 2023 | 113 | 0.270 |
Why?
| | Analgesia, Patient-Controlled | 2 | 2019 | 17 | 0.260 |
Why?
| | Relative Value Scales | 1 | 2006 | 2 | 0.260 |
Why?
| | Insurance, Health, Reimbursement | 1 | 2006 | 4 | 0.260 |
Why?
| | Bone Morphogenetic Protein Receptors, Type II | 1 | 2005 | 1 | 0.260 |
Why?
| | Bone Morphogenetic Protein Receptors, Type I | 1 | 2005 | 3 | 0.260 |
Why?
| | Urethra | 1 | 2005 | 5 | 0.260 |
Why?
| | Urinary Bladder | 1 | 2005 | 8 | 0.260 |
Why?
| | Gestational Age | 4 | 2013 | 62 | 0.260 |
Why?
| | Orchiopexy | 2 | 2015 | 7 | 0.250 |
Why?
| | Middle Aged | 6 | 2024 | 614 | 0.250 |
Why?
| | Testis | 2 | 2015 | 26 | 0.250 |
Why?
| | Emergency Service, Hospital | 2 | 2017 | 131 | 0.250 |
Why?
| | Catheterization, Central Venous | 4 | 1995 | 18 | 0.250 |
Why?
| | Infant, Premature, Diseases | 2 | 2003 | 22 | 0.240 |
Why?
| | Olfaction Disorders | 1 | 2024 | 1 | 0.240 |
Why?
| | Case-Control Studies | 5 | 2011 | 216 | 0.240 |
Why?
| | Liver | 3 | 2023 | 126 | 0.240 |
Why?
| | Chest Tubes | 3 | 2023 | 21 | 0.240 |
Why?
| | Early Detection of Cancer | 1 | 2024 | 12 | 0.240 |
Why?
| | Mental Health | 1 | 2024 | 20 | 0.240 |
Why?
| | Diagnostic Tests, Routine | 2 | 2020 | 19 | 0.240 |
Why?
| | Adaptation, Psychological | 1 | 2024 | 39 | 0.230 |
Why?
| | Enteral Nutrition | 4 | 2023 | 61 | 0.230 |
Why?
| | Ceftriaxone | 3 | 2010 | 13 | 0.230 |
Why?
| | Metronidazole | 3 | 2010 | 16 | 0.230 |
Why?
| | Infant, Premature | 3 | 2003 | 84 | 0.230 |
Why?
| | Lung Neoplasms | 4 | 2008 | 23 | 0.230 |
Why?
| | Cost-Benefit Analysis | 4 | 2020 | 27 | 0.230 |
Why?
| | Appendix | 2 | 2016 | 11 | 0.220 |
Why?
| | Genetic Testing | 1 | 2024 | 87 | 0.220 |
Why?
| | Quality of Life | 1 | 2024 | 143 | 0.220 |
Why?
| | Tissue Adhesions | 2 | 2017 | 9 | 0.220 |
Why?
| | Pregnancy | 5 | 2008 | 214 | 0.220 |
Why?
| | Time Factors | 5 | 2016 | 238 | 0.210 |
Why?
| | Probability | 3 | 2020 | 15 | 0.210 |
Why?
| | Esophageal Stenosis | 3 | 2010 | 7 | 0.210 |
Why?
| | Bed Rest | 2 | 2013 | 8 | 0.210 |
Why?
| | Drainage | 5 | 2010 | 36 | 0.200 |
Why?
| | Body Weights and Measures | 1 | 2022 | 2 | 0.200 |
Why?
| | Sex Factors | 2 | 2014 | 69 | 0.200 |
Why?
| | Postoperative Care | 2 | 2013 | 30 | 0.200 |
Why?
| | Age of Onset | 3 | 2013 | 28 | 0.200 |
Why?
| | Birth Weight | 4 | 2005 | 28 | 0.200 |
Why?
| | Masks | 1 | 2021 | 6 | 0.200 |
Why?
| | Intubation, Gastrointestinal | 4 | 2010 | 20 | 0.190 |
Why?
| | Device Removal | 3 | 2014 | 14 | 0.190 |
Why?
| | Osteosarcoma | 3 | 1993 | 20 | 0.190 |
Why?
| | Animals | 12 | 2006 | 657 | 0.190 |
Why?
| | Age Factors | 4 | 2010 | 211 | 0.190 |
Why?
| | Nerve Tissue Proteins | 2 | 2003 | 26 | 0.180 |
Why?
| | Superior Mesenteric Artery Syndrome | 1 | 2020 | 4 | 0.180 |
Why?
| | Ligaments | 1 | 2020 | 4 | 0.180 |
Why?
| | Immunohistochemistry | 4 | 2006 | 44 | 0.180 |
Why?
| | Birth Injuries | 1 | 2000 | 1 | 0.180 |
Why?
| | Splenic Rupture | 1 | 2000 | 2 | 0.180 |
Why?
| | Computer-Assisted Instruction | 1 | 2020 | 3 | 0.180 |
Why?
| | Inpatients | 1 | 2020 | 44 | 0.170 |
Why?
| | Surgeons | 1 | 2020 | 7 | 0.170 |
Why?
| | Thoracic Surgical Procedures | 3 | 2010 | 9 | 0.170 |
Why?
| | Bile Duct Diseases | 1 | 2000 | 1 | 0.170 |
Why?
| | Internet | 1 | 2020 | 17 | 0.170 |
Why?
| | Cysts | 1 | 2000 | 4 | 0.170 |
Why?
| | Patient Discharge | 1 | 2020 | 57 | 0.170 |
Why?
| | Bayes Theorem | 1 | 2020 | 30 | 0.170 |
Why?
| | Reoperation | 5 | 2022 | 61 | 0.170 |
Why?
| | Manipulation, Orthopedic | 1 | 2019 | 4 | 0.170 |
Why?
| | Gastrointestinal Hemorrhage | 1 | 2019 | 15 | 0.160 |
Why?
| | Apgar Score | 3 | 2005 | 6 | 0.160 |
Why?
| | Combined Modality Therapy | 2 | 2016 | 46 | 0.150 |
Why?
| | Prostheses and Implants | 2 | 2011 | 7 | 0.150 |
Why?
| | Medical Staff, Hospital | 2 | 2008 | 4 | 0.150 |
Why?
| | Doxorubicin | 4 | 2006 | 15 | 0.150 |
Why?
| | Survival Rate | 7 | 2003 | 83 | 0.150 |
Why?
| | Cyanoacrylates | 1 | 2017 | 2 | 0.150 |
Why?
| | Tissue Adhesives | 1 | 2017 | 3 | 0.150 |
Why?
| | Circumcision, Male | 1 | 2017 | 3 | 0.150 |
Why?
| | Hospitals, Low-Volume | 1 | 2017 | 1 | 0.150 |
Why?
| | Hospitals, High-Volume | 1 | 2017 | 3 | 0.150 |
Why?
| | Rats | 6 | 2006 | 105 | 0.150 |
Why?
| | Enterocolitis, Pseudomembranous | 1 | 1997 | 4 | 0.140 |
Why?
| | Infant, Very Low Birth Weight | 1 | 1997 | 10 | 0.140 |
Why?
| | Rats, Sprague-Dawley | 5 | 2006 | 50 | 0.140 |
Why?
| | Abscess | 2 | 2008 | 10 | 0.140 |
Why?
| | Patient Satisfaction | 3 | 2019 | 37 | 0.140 |
Why?
| | Pylorus | 3 | 2006 | 12 | 0.140 |
Why?
| | Surgicenters | 1 | 2016 | 2 | 0.140 |
Why?
| | Models, Organizational | 1 | 2016 | 7 | 0.140 |
Why?
| | Therapeutic Irrigation | 1 | 2016 | 11 | 0.130 |
Why?
| | Antibiotic Prophylaxis | 3 | 2021 | 30 | 0.130 |
Why?
| | Clinical Protocols | 2 | 2013 | 28 | 0.130 |
Why?
| | Aged | 4 | 2024 | 382 | 0.130 |
Why?
| | Preoperative Care | 4 | 2010 | 26 | 0.130 |
Why?
| | Cohort Studies | 4 | 2010 | 288 | 0.130 |
Why?
| | Presynaptic Terminals | 1 | 1995 | 1 | 0.130 |
Why?
| | Corpus Striatum | 1 | 1995 | 2 | 0.130 |
Why?
| | Cerebral Cortex | 1 | 1995 | 6 | 0.130 |
Why?
| | Peritoneal Lavage | 2 | 2012 | 5 | 0.130 |
Why?
| | Age Distribution | 2 | 2012 | 31 | 0.130 |
Why?
| | Thoracoscopy | 4 | 2011 | 28 | 0.130 |
Why?
| | Membrane Proteins | 1 | 1995 | 54 | 0.120 |
Why?
| | Gastric Emptying | 1 | 1995 | 9 | 0.120 |
Why?
| | Xiphoid Bone | 2 | 2016 | 4 | 0.120 |
Why?
| | Gastric Fistula | 1 | 2015 | 3 | 0.120 |
Why?
| | Cutaneous Fistula | 1 | 2015 | 3 | 0.120 |
Why?
| | Ranitidine | 1 | 2015 | 5 | 0.120 |
Why?
| | Histamine H2 Antagonists | 1 | 2015 | 7 | 0.120 |
Why?
| | Abnormalities, Drug-Induced | 2 | 2006 | 8 | 0.120 |
Why?
| | Proton Pump Inhibitors | 1 | 2015 | 17 | 0.120 |
Why?
| | Needs Assessment | 2 | 2020 | 18 | 0.120 |
Why?
| | Kidney | 2 | 2009 | 96 | 0.120 |
Why?
| | Kansas | 1 | 2014 | 43 | 0.120 |
Why?
| | Blood Volume | 3 | 1991 | 4 | 0.120 |
Why?
| | Breast Neoplasms | 2 | 2024 | 38 | 0.110 |
Why?
| | Reproducibility of Results | 2 | 2011 | 201 | 0.110 |
Why?
| | Receptors, Fibroblast Growth Factor | 2 | 2004 | 2 | 0.110 |
Why?
| | Injury Severity Score | 4 | 2023 | 52 | 0.110 |
Why?
| | Prosthesis Implantation | 2 | 2010 | 5 | 0.110 |
Why?
| | Esthetics | 2 | 2011 | 7 | 0.110 |
Why?
| | Multiple Birth Offspring | 1 | 2013 | 2 | 0.110 |
Why?
| | Biopsy | 2 | 2010 | 61 | 0.110 |
Why?
| | Competitive Behavior | 1 | 2013 | 2 | 0.110 |
Why?
| | Job Application | 1 | 2013 | 2 | 0.110 |
Why?
| | Trans-Activators | 2 | 2003 | 13 | 0.110 |
Why?
| | Operative Time | 3 | 2022 | 28 | 0.110 |
Why?
| | Longitudinal Studies | 2 | 2010 | 119 | 0.110 |
Why?
| | Confidence Intervals | 1 | 2012 | 12 | 0.110 |
Why?
| | Sex Distribution | 1 | 2012 | 17 | 0.110 |
Why?
| | Odds Ratio | 1 | 2012 | 51 | 0.110 |
Why?
| | Prevalence | 1 | 2013 | 150 | 0.100 |
Why?
| | Suction | 1 | 2012 | 6 | 0.100 |
Why?
| | Fluoroscopy | 3 | 2013 | 19 | 0.100 |
Why?
| | Fluid Therapy | 2 | 2023 | 17 | 0.100 |
Why?
| | Disease Models, Animal | 3 | 2006 | 70 | 0.100 |
Why?
| | Anus, Imperforate | 1 | 2012 | 5 | 0.100 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 5 | 2003 | 67 | 0.100 |
Why?
| | Duodenoscopy | 2 | 2008 | 3 | 0.100 |
Why?
| | Thoracic Vertebrae | 1 | 2011 | 3 | 0.100 |
Why?
| | Sternum | 1 | 2011 | 5 | 0.100 |
Why?
| | Anthropometry | 1 | 2011 | 15 | 0.100 |
Why?
| | Insufflation | 1 | 2011 | 2 | 0.100 |
Why?
| | Pneumoperitoneum, Artificial | 1 | 2011 | 4 | 0.100 |
Why?
| | Trachea | 3 | 2007 | 7 | 0.100 |
Why?
| | Diagnosis, Differential | 2 | 2005 | 77 | 0.100 |
Why?
| | Mediastinum | 1 | 2011 | 5 | 0.100 |
Why?
| | Bone Neoplasms | 1 | 1991 | 24 | 0.100 |
Why?
| | Enterostomy | 1 | 1991 | 2 | 0.100 |
Why?
| | Ultraviolet Rays | 1 | 1991 | 5 | 0.100 |
Why?
| | Fluorescent Dyes | 1 | 1991 | 7 | 0.100 |
Why?
| | Thorax | 1 | 2011 | 4 | 0.090 |
Why?
| | Axilla | 1 | 2011 | 1 | 0.090 |
Why?
| | Buttocks | 1 | 2011 | 1 | 0.090 |
Why?
| | Lymphoma | 1 | 2011 | 9 | 0.090 |
Why?
| | Leukemia | 1 | 2011 | 15 | 0.090 |
Why?
| | Surveys and Questionnaires | 2 | 2024 | 275 | 0.090 |
Why?
| | Water-Electrolyte Imbalance | 1 | 1990 | 1 | 0.090 |
Why?
| | Blood Pressure Monitors | 1 | 1990 | 1 | 0.090 |
Why?
| | Diaphragm | 1 | 2010 | 5 | 0.090 |
Why?
| | Jejunal Diseases | 1 | 1990 | 3 | 0.090 |
Why?
| | Syndrome | 2 | 2008 | 34 | 0.090 |
Why?
| | Patient Admission | 1 | 2010 | 9 | 0.090 |
Why?
| | Bone Marrow Transplantation | 1 | 1990 | 17 | 0.090 |
Why?
| | Kidney Pelvis | 1 | 2010 | 1 | 0.090 |
Why?
| | Ureteral Obstruction | 1 | 2010 | 4 | 0.090 |
Why?
| | Diagnostic Techniques, Digestive System | 1 | 2010 | 5 | 0.090 |
Why?
| | Decompression, Surgical | 1 | 2010 | 5 | 0.090 |
Why?
| | Nutritional Support | 1 | 2010 | 5 | 0.090 |
Why?
| | Esophageal pH Monitoring | 1 | 2010 | 4 | 0.090 |
Why?
| | Esophageal Perforation | 1 | 2010 | 4 | 0.090 |
Why?
| | Predictive Value of Tests | 4 | 2011 | 100 | 0.090 |
Why?
| | Nephrectomy | 1 | 2010 | 14 | 0.090 |
Why?
| | Gastrointestinal Tract | 1 | 2010 | 7 | 0.090 |
Why?
| | Nipples | 1 | 2010 | 3 | 0.090 |
Why?
| | Fecal Incontinence | 1 | 2010 | 26 | 0.090 |
Why?
| | Logistic Models | 3 | 2017 | 85 | 0.090 |
Why?
| | Pneumonia | 1 | 1990 | 32 | 0.090 |
Why?
| | Nuclear Proteins | 4 | 2003 | 52 | 0.090 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 1 | 2010 | 4 | 0.090 |
Why?
| | Magnetic Resonance Imaging | 1 | 2011 | 122 | 0.090 |
Why?
| | Ultrasonography | 3 | 2006 | 47 | 0.090 |
Why?
| | Leukemic Infiltration | 1 | 2009 | 3 | 0.090 |
Why?
| | Azygos Vein | 1 | 1989 | 1 | 0.080 |
Why?
| | Cystic Fibrosis | 1 | 1989 | 18 | 0.080 |
Why?
| | Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2009 | 53 | 0.080 |
Why?
| | Sensitivity and Specificity | 4 | 2011 | 149 | 0.080 |
Why?
| | Pressure | 2 | 2019 | 9 | 0.080 |
Why?
| | DNA-Binding Proteins | 3 | 2003 | 39 | 0.080 |
Why?
| | Workload | 1 | 2008 | 8 | 0.080 |
Why?
| | Gentamicins | 1 | 2008 | 5 | 0.080 |
Why?
| | Pregnancy in Diabetics | 1 | 2008 | 2 | 0.080 |
Why?
| | Ileus | 1 | 2008 | 3 | 0.080 |
Why?
| | Electrolytes | 2 | 2021 | 11 | 0.080 |
Why?
| | Transcription Factors | 3 | 2003 | 51 | 0.080 |
Why?
| | Rural Health Services | 1 | 2008 | 2 | 0.080 |
Why?
| | Urban Health Services | 1 | 2008 | 3 | 0.080 |
Why?
| | Patient Care Team | 1 | 2008 | 18 | 0.080 |
Why?
| | Comorbidity | 1 | 2008 | 56 | 0.080 |
Why?
| | Health Care Costs | 2 | 2005 | 34 | 0.080 |
Why?
| | RNA, Messenger | 3 | 2004 | 112 | 0.070 |
Why?
| | Societies, Medical | 1 | 2008 | 51 | 0.070 |
Why?
| | Anastomosis, Surgical | 2 | 2023 | 21 | 0.070 |
Why?
| | Hospital Charges | 1 | 2007 | 11 | 0.070 |
Why?
| | Herniorrhaphy | 2 | 2021 | 24 | 0.070 |
Why?
| | Cost of Illness | 1 | 2007 | 22 | 0.070 |
Why?
| | Vomiting | 3 | 2020 | 23 | 0.070 |
Why?
| | Intestine, Small | 1 | 2007 | 15 | 0.070 |
Why?
| | Antithrombin III | 1 | 2007 | 2 | 0.070 |
Why?
| | Disseminated Intravascular Coagulation | 1 | 2007 | 2 | 0.070 |
Why?
| | Spinal Diseases | 1 | 2007 | 2 | 0.070 |
Why?
| | Survival Analysis | 3 | 2008 | 50 | 0.070 |
Why?
| | Anticoagulants | 1 | 2007 | 18 | 0.070 |
Why?
| | Urinary Tract | 1 | 2007 | 10 | 0.070 |
Why?
| | Disorders of Sex Development | 1 | 2006 | 10 | 0.070 |
Why?
| | Teratogens | 1 | 2006 | 4 | 0.070 |
Why?
| | Fibroblast Growth Factors | 2 | 2004 | 30 | 0.070 |
Why?
| | Urination | 1 | 2005 | 2 | 0.070 |
Why?
| | Ligands | 1 | 2005 | 5 | 0.070 |
Why?
| | Regression Analysis | 1 | 2006 | 52 | 0.070 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2003 | 38 | 0.060 |
Why?
| | Cesarean Section | 1 | 2005 | 5 | 0.060 |
Why?
| | Constriction, Pathologic | 2 | 2023 | 18 | 0.060 |
Why?
| | Islets of Langerhans | 1 | 2005 | 3 | 0.060 |
Why?
| | Glucagon-Like Peptide 1 | 1 | 2005 | 2 | 0.060 |
Why?
| | Transforming Growth Factor beta | 1 | 2005 | 11 | 0.060 |
Why?
| | Drug Therapy, Combination | 3 | 2010 | 35 | 0.060 |
Why?
| | Urologic Surgical Procedures | 1 | 2005 | 1 | 0.060 |
Why?
| | Diverticulum | 1 | 2005 | 4 | 0.060 |
Why?
| | Urinary Bladder Diseases | 1 | 2005 | 3 | 0.060 |
Why?
| | Treatment Failure | 1 | 2005 | 18 | 0.060 |
Why?
| | Staphylococcal Infections | 1 | 2005 | 21 | 0.060 |
Why?
| | Texas | 2 | 2023 | 20 | 0.060 |
Why?
| | Georgia | 1 | 2024 | 3 | 0.060 |
Why?
| | Mass Screening | 1 | 2024 | 35 | 0.060 |
Why?
| | Thyroglossal Cyst | 1 | 2004 | 1 | 0.060 |
Why?
| | Rural Population | 1 | 2024 | 37 | 0.060 |
Why?
| | Anxiety | 1 | 2024 | 51 | 0.060 |
Why?
| | Depression | 1 | 2024 | 69 | 0.060 |
Why?
| | Administration, Oral | 3 | 2010 | 58 | 0.060 |
Why?
| | Bacterial Infections | 1 | 2004 | 27 | 0.060 |
Why?
| | Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2003 | 2 | 0.060 |
Why?
| | Radiography | 3 | 2010 | 37 | 0.060 |
Why?
| | Causality | 1 | 2003 | 10 | 0.060 |
Why?
| | Foreign-Body Reaction | 1 | 2003 | 3 | 0.060 |
Why?
| | DNA Mutational Analysis | 1 | 2003 | 42 | 0.060 |
Why?
| | Osteogenesis | 1 | 2003 | 6 | 0.050 |
Why?
| | Anastomotic Leak | 1 | 2023 | 9 | 0.050 |
Why?
| | Thoracic Injuries | 2 | 1996 | 7 | 0.050 |
Why?
| | Fetal Proteins | 1 | 2003 | 1 | 0.050 |
Why?
| | Arizona | 1 | 2023 | 8 | 0.050 |
Why?
| | Arkansas | 1 | 2023 | 8 | 0.050 |
Why?
| | Oklahoma | 1 | 2023 | 10 | 0.050 |
Why?
| | Genetic Predisposition to Disease | 1 | 2024 | 230 | 0.050 |
Why?
| | Trauma Centers | 1 | 2023 | 37 | 0.050 |
Why?
| | Thoracic Surgery, Video-Assisted | 1 | 2023 | 20 | 0.050 |
Why?
| | Rupture, Spontaneous | 3 | 2011 | 7 | 0.050 |
Why?
| | Blood Loss, Surgical | 3 | 2012 | 5 | 0.050 |
Why?
| | Pilot Projects | 2 | 2015 | 118 | 0.050 |
Why?
| | Ovarian Neoplasms | 1 | 2003 | 136 | 0.050 |
Why?
| | Intercostal Nerves | 1 | 2022 | 6 | 0.050 |
Why?
| | Ribonucleases | 1 | 2001 | 2 | 0.050 |
Why?
| | Tubulin | 1 | 2001 | 5 | 0.050 |
Why?
| | Carbon Dioxide | 1 | 2021 | 14 | 0.050 |
Why?
| | Pancreas | 1 | 2001 | 9 | 0.050 |
Why?
| | Hospitals | 1 | 2021 | 36 | 0.050 |
Why?
| | Thoracic Arteries | 1 | 2001 | 1 | 0.050 |
Why?
| | Tracheal Stenosis | 1 | 2001 | 1 | 0.050 |
Why?
| | Anal Canal | 1 | 2021 | 26 | 0.050 |
Why?
| | Outpatients | 1 | 2021 | 27 | 0.050 |
Why?
| | Antibodies | 2 | 2005 | 15 | 0.050 |
Why?
| | Rotation | 1 | 2020 | 5 | 0.040 |
Why?
| | Hemoperitoneum | 1 | 2000 | 2 | 0.040 |
Why?
| | Nausea | 1 | 2020 | 16 | 0.040 |
Why?
| | Dilatation, Pathologic | 1 | 2000 | 6 | 0.040 |
Why?
| | Pleural Diseases | 2 | 2011 | 5 | 0.040 |
Why?
| | Pain | 1 | 2020 | 55 | 0.040 |
Why?
| | Morbidity | 1 | 1999 | 11 | 0.040 |
Why?
| | DNA Nucleotidylexotransferase | 1 | 1999 | 3 | 0.040 |
Why?
| | Morphogenesis | 3 | 2004 | 8 | 0.040 |
Why?
| | Young Adult | 2 | 2012 | 657 | 0.040 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2010 | 95 | 0.040 |
Why?
| | Patient Compliance | 1 | 2019 | 55 | 0.040 |
Why?
| | Lung | 3 | 2004 | 65 | 0.040 |
Why?
| | Respiratory Tract Diseases | 2 | 2014 | 7 | 0.040 |
Why?
| | Vena Cava, Inferior | 1 | 1998 | 3 | 0.040 |
Why?
| | Ductus Arteriosus, Patent | 1 | 1998 | 4 | 0.040 |
Why?
| | Colectomy | 2 | 1996 | 14 | 0.040 |
Why?
| | Turner Syndrome | 1 | 1998 | 10 | 0.040 |
Why?
| | Laser Therapy | 3 | 1996 | 4 | 0.040 |
Why?
| | Endoscopy | 1 | 1998 | 14 | 0.040 |
Why?
| | Risk Adjustment | 1 | 2017 | 5 | 0.040 |
Why?
| | Sutures | 1 | 2017 | 11 | 0.040 |
Why?
| | Quality Assurance, Health Care | 1 | 2017 | 7 | 0.040 |
Why?
| | Quality Indicators, Health Care | 1 | 2017 | 16 | 0.040 |
Why?
| | Missouri | 3 | 2007 | 80 | 0.040 |
Why?
| | Linear Models | 1 | 2017 | 56 | 0.040 |
Why?
| | Mice | 3 | 2005 | 345 | 0.040 |
Why?
| | Infusions, Intravenous | 2 | 2008 | 26 | 0.030 |
Why?
| | Dogs | 3 | 1990 | 17 | 0.030 |
Why?
| | Tracheal Diseases | 1 | 1996 | 1 | 0.030 |
Why?
| | Aorta | 1 | 1996 | 8 | 0.030 |
Why?
| | Nervous System Diseases | 1 | 1996 | 12 | 0.030 |
Why?
| | Colitis, Ulcerative | 1 | 1996 | 13 | 0.030 |
Why?
| | Inguinal Canal | 1 | 2015 | 3 | 0.030 |
Why?
| | Atrophy | 1 | 2015 | 6 | 0.030 |
Why?
| | Constriction | 1 | 1995 | 1 | 0.030 |
Why?
| | Needles | 1 | 1995 | 3 | 0.030 |
Why?
| | Adenomatous Polyposis Coli | 1 | 1996 | 24 | 0.030 |
Why?
| | Intestinal Mucosa | 1 | 1996 | 41 | 0.030 |
Why?
| | Syntaxin 1 | 1 | 1995 | 1 | 0.030 |
Why?
| | Microscopy, Electron | 1 | 1995 | 5 | 0.030 |
Why?
| | Qa-SNARE Proteins | 1 | 1995 | 2 | 0.030 |
Why?
| | Remission, Spontaneous | 1 | 2015 | 2 | 0.030 |
Why?
| | Gastrointestinal Motility | 2 | 2010 | 6 | 0.030 |
Why?
| | Hospitalization | 2 | 2011 | 217 | 0.030 |
Why?
| | Accidents, Traffic | 2 | 1996 | 18 | 0.030 |
Why?
| | Cecal Diseases | 1 | 2014 | 2 | 0.030 |
Why?
| | Enterobiasis | 1 | 2014 | 2 | 0.030 |
Why?
| | Granuloma | 1 | 2014 | 4 | 0.030 |
Why?
| | Incidental Findings | 1 | 2014 | 8 | 0.030 |
Why?
| | Appendiceal Neoplasms | 1 | 2014 | 3 | 0.030 |
Why?
| | Carcinoid Tumor | 1 | 2014 | 3 | 0.030 |
Why?
| | Intestinal Neoplasms | 1 | 2014 | 3 | 0.030 |
Why?
| | Thoracostomy | 1 | 2014 | 7 | 0.030 |
Why?
| | Hemodynamics | 2 | 1991 | 10 | 0.030 |
Why?
| | Radiography, Thoracic | 1 | 2014 | 10 | 0.030 |
Why?
| | Vena Cava, Superior | 1 | 1993 | 1 | 0.030 |
Why?
| | Meconium Aspiration Syndrome | 1 | 1993 | 4 | 0.030 |
Why?
| | Femoral Artery | 1 | 1973 | 1 | 0.030 |
Why?
| | Solutions | 1 | 2013 | 3 | 0.030 |
Why?
| | Cerebral Hemorrhage | 1 | 1993 | 1 | 0.030 |
Why?
| | Jugular Veins | 1 | 1993 | 3 | 0.030 |
Why?
| | Sarcoma | 1 | 1993 | 6 | 0.030 |
Why?
| | Angiography | 1 | 1973 | 8 | 0.030 |
Why?
| | Postoperative Nausea and Vomiting | 1 | 2013 | 5 | 0.030 |
Why?
| | Receptor, Fibroblast Growth Factor, Type 2 | 2 | 2004 | 2 | 0.030 |
Why?
| | Appointments and Schedules | 1 | 2013 | 12 | 0.030 |
Why?
| | Thrombosis | 1 | 1973 | 14 | 0.030 |
Why?
| | Infant Formula | 1 | 2013 | 15 | 0.030 |
Why?
| | Eosinophilia | 1 | 2014 | 29 | 0.030 |
Why?
| | Milk, Human | 1 | 2013 | 23 | 0.030 |
Why?
| | Remission Induction | 1 | 2013 | 24 | 0.030 |
Why?
| | Embryonic and Fetal Development | 2 | 2003 | 5 | 0.030 |
Why?
| | Kruppel-Like Transcription Factors | 2 | 2003 | 6 | 0.030 |
Why?
| | Hedgehog Proteins | 2 | 2003 | 6 | 0.030 |
Why?
| | Epithelium | 2 | 2003 | 7 | 0.030 |
Why?
| | Polymerase Chain Reaction | 2 | 2004 | 83 | 0.030 |
Why?
| | Intention to Treat Analysis | 1 | 2012 | 7 | 0.030 |
Why?
| | Cellulitis | 2 | 2005 | 6 | 0.030 |
Why?
| | Chi-Square Distribution | 2 | 2007 | 33 | 0.020 |
Why?
| | False Negative Reactions | 1 | 2011 | 9 | 0.020 |
Why?
| | Single-Blind Method | 1 | 2011 | 12 | 0.020 |
Why?
| | Palpation | 1 | 1991 | 1 | 0.020 |
Why?
| | Blister | 1 | 2011 | 2 | 0.020 |
Why?
| | Regional Blood Flow | 1 | 1991 | 3 | 0.020 |
Why?
| | Ischemia | 1 | 1991 | 7 | 0.020 |
Why?
| | Splenectomy | 1 | 2011 | 8 | 0.020 |
Why?
| | Death | 1 | 1991 | 2 | 0.020 |
Why?
| | Resuscitation | 2 | 1991 | 6 | 0.020 |
Why?
| | Shock, Hemorrhagic | 1 | 1991 | 5 | 0.020 |
Why?
| | Early Ambulation | 1 | 2011 | 3 | 0.020 |
Why?
| | Guidelines as Topic | 1 | 2011 | 11 | 0.020 |
Why?
| | Intestines | 1 | 1991 | 29 | 0.020 |
Why?
| | Pulmonary Wedge Pressure | 1 | 1990 | 3 | 0.020 |
Why?
| | Wound Infection | 1 | 1990 | 3 | 0.020 |
Why?
| | Evaluation Studies as Topic | 1 | 1990 | 7 | 0.020 |
Why?
| | Minnesota | 1 | 1990 | 6 | 0.020 |
Why?
| | Extracellular Space | 1 | 1990 | 4 | 0.020 |
Why?
| | Blood Pressure Determination | 1 | 1990 | 14 | 0.020 |
Why?
| | Bronchoscopy | 1 | 1990 | 7 | 0.020 |
Why?
| | Immune Tolerance | 1 | 1990 | 8 | 0.020 |
Why?
| | Opportunistic Infections | 1 | 1990 | 7 | 0.020 |
Why?
| | Cholestasis, Extrahepatic | 1 | 1990 | 1 | 0.020 |
Why?
| | Amoxicillin | 1 | 2010 | 4 | 0.020 |
Why?
| | Ascites | 1 | 1990 | 4 | 0.020 |
Why?
| | Injections, Intravenous | 1 | 2010 | 15 | 0.020 |
Why?
| | Prosthesis Design | 1 | 2010 | 8 | 0.020 |
Why?
| | Iatrogenic Disease | 1 | 2010 | 7 | 0.020 |
Why?
| | Diagnostic Errors | 1 | 2010 | 7 | 0.020 |
Why?
| | Attitude | 1 | 2010 | 9 | 0.020 |
Why?
| | Hydrocephalus | 1 | 1989 | 8 | 0.020 |
Why?
| | Clinical Competence | 1 | 2010 | 28 | 0.020 |
Why?
| | Hypertrophy | 1 | 2009 | 4 | 0.020 |
Why?
| | Fever | 1 | 2009 | 26 | 0.020 |
Why?
| | Attitude of Health Personnel | 1 | 2010 | 41 | 0.020 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2009 | 59 | 0.020 |
Why?
| | Cholecystectomy | 1 | 1989 | 9 | 0.020 |
Why?
| | Respiratory Function Tests | 1 | 1989 | 16 | 0.020 |
Why?
| | Body Mass Index | 1 | 2009 | 157 | 0.020 |
Why?
| | Hemangioma, Cavernous | 1 | 1988 | 1 | 0.020 |
Why?
| | Peritoneal Neoplasms | 1 | 1988 | 2 | 0.020 |
Why?
| | Colonic Neoplasms | 1 | 1988 | 7 | 0.020 |
Why?
| | Work Schedule Tolerance | 1 | 2008 | 5 | 0.020 |
Why?
| | Quality of Health Care | 1 | 2008 | 11 | 0.020 |
Why?
| | Personnel Staffing and Scheduling | 1 | 2008 | 13 | 0.020 |
Why?
| | Drug Administration Schedule | 1 | 2008 | 35 | 0.020 |
Why?
| | Health Care Surveys | 1 | 2008 | 33 | 0.020 |
Why?
| | Multivariate Analysis | 1 | 2008 | 71 | 0.020 |
Why?
| | Hospital Costs | 1 | 2008 | 29 | 0.020 |
Why?
| | Esophageal Fistula | 1 | 2008 | 2 | 0.020 |
Why?
| | Thoracic Neoplasms | 1 | 2008 | 2 | 0.020 |
Why?
| | Respiratory Tract Fistula | 1 | 2008 | 2 | 0.020 |
Why?
| | Hemothorax | 1 | 2008 | 3 | 0.020 |
Why?
| | Cholangiography | 1 | 2008 | 2 | 0.020 |
Why?
| | Cystic Duct | 1 | 2008 | 2 | 0.020 |
Why?
| | Choledocholithiasis | 1 | 2008 | 2 | 0.020 |
Why?
| | Bronchial Fistula | 1 | 2008 | 3 | 0.020 |
Why?
| | Pneumonectomy | 1 | 2008 | 4 | 0.020 |
Why?
| | Empyema | 1 | 2008 | 3 | 0.020 |
Why?
| | Gallstones | 1 | 2008 | 4 | 0.020 |
Why?
| | Scoliosis | 1 | 2008 | 6 | 0.020 |
Why?
| | Pleural Effusion | 1 | 2008 | 5 | 0.020 |
Why?
| | Pancreatitis | 1 | 2008 | 8 | 0.020 |
Why?
| | Cholecystitis | 1 | 2008 | 6 | 0.020 |
Why?
| | Biliary Dyskinesia | 1 | 2008 | 9 | 0.020 |
Why?
| | Pharmacy Service, Hospital | 1 | 2007 | 8 | 0.020 |
Why?
| | Operating Rooms | 1 | 2007 | 5 | 0.020 |
Why?
| | Intestinal Volvulus | 1 | 2007 | 11 | 0.020 |
Why?
| | Blood Transfusion | 1 | 2007 | 13 | 0.020 |
Why?
| | Hemorrhage | 1 | 1987 | 19 | 0.020 |
Why?
| | Monitoring, Physiologic | 1 | 1987 | 22 | 0.020 |
Why?
| | Pancreas, Exocrine | 1 | 2005 | 1 | 0.020 |
Why?
| | Transforming Growth Factor beta1 | 1 | 2005 | 1 | 0.020 |
Why?
| | Mice, Inbred Strains | 1 | 2005 | 5 | 0.020 |
Why?
| | Venoms | 1 | 2005 | 2 | 0.020 |
Why?
| | Drug Synergism | 1 | 2005 | 7 | 0.020 |
Why?
| | Wound Healing | 1 | 2005 | 6 | 0.020 |
Why?
| | Peptides | 1 | 2005 | 11 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2005 | 81 | 0.020 |
Why?
| | Stem Cells | 1 | 2005 | 28 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2005 | 47 | 0.020 |
Why?
| | Urination Disorders | 1 | 2005 | 4 | 0.020 |
Why?
| | Urinary Tract Infections | 1 | 2005 | 25 | 0.020 |
Why?
| | Models, Animal | 1 | 2004 | 8 | 0.010 |
Why?
| | Neck | 1 | 2004 | 7 | 0.010 |
Why?
| | MutS Homolog 2 Protein | 1 | 2003 | 1 | 0.010 |
Why?
| | Organ Culture Techniques | 1 | 2003 | 3 | 0.010 |
Why?
| | Embryo, Mammalian | 1 | 2003 | 5 | 0.010 |
Why?
| | Genes, BRCA2 | 1 | 2003 | 5 | 0.010 |
Why?
| | Genes, BRCA1 | 1 | 2003 | 6 | 0.010 |
Why?
| | Proto-Oncogene Proteins | 1 | 2003 | 18 | 0.010 |
Why?
| | Neoplasm Proteins | 1 | 2003 | 30 | 0.010 |
Why?
| | Pedigree | 1 | 2003 | 59 | 0.010 |
Why?
| | Carrier Proteins | 1 | 2003 | 36 | 0.010 |
Why?
| | Mesoderm | 1 | 2003 | 1 | 0.010 |
Why?
| | Fibroblast Growth Factor 7 | 1 | 2003 | 2 | 0.010 |
Why?
| | Oncogene Proteins | 1 | 2003 | 2 | 0.010 |
Why?
| | Connective Tissue | 1 | 2003 | 2 | 0.010 |
Why?
| | Muscle, Smooth | 1 | 2003 | 2 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2003 | 151 | 0.010 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2003 | 40 | 0.010 |
Why?
| | Phenotype | 1 | 2004 | 260 | 0.010 |
Why?
| | Respiratory Mucosa | 1 | 2002 | 4 | 0.010 |
Why?
| | Equipment Failure | 1 | 2002 | 10 | 0.010 |
Why?
| | Catheters, Indwelling | 1 | 2002 | 31 | 0.010 |
Why?
| | Lung Diseases | 1 | 2002 | 23 | 0.010 |
Why?
| | Registries | 1 | 2002 | 95 | 0.010 |
Why?
| | Cell Division | 1 | 2001 | 7 | 0.010 |
Why?
| | Kidney Diseases | 1 | 2002 | 71 | 0.010 |
Why?
| | Cell Count | 1 | 2001 | 16 | 0.010 |
Why?
| | Cardiovascular Diseases | 1 | 2002 | 48 | 0.010 |
Why?
| | Subclavian Artery | 1 | 2001 | 1 | 0.010 |
Why?
| | Brachiocephalic Trunk | 1 | 2001 | 1 | 0.010 |
Why?
| | Pulmonary Artery | 1 | 2001 | 10 | 0.010 |
Why?
| | Aorta, Thoracic | 1 | 2001 | 9 | 0.010 |
Why?
| | Managed Care Programs | 1 | 2001 | 3 | 0.010 |
Why?
| | Insulin | 1 | 2001 | 50 | 0.010 |
Why?
| | Echocardiography | 1 | 2001 | 81 | 0.010 |
Why?
| | Deoxyadenine Nucleotides | 1 | 1999 | 1 | 0.010 |
Why?
| | Deoxycytosine Nucleotides | 1 | 1999 | 1 | 0.010 |
Why?
| | Thymine Nucleotides | 1 | 1999 | 1 | 0.010 |
Why?
| | DNA-Activated Protein Kinase | 1 | 1999 | 1 | 0.010 |
Why?
| | Deoxyguanine Nucleotides | 1 | 1999 | 2 | 0.010 |
Why?
| | Catalysis | 1 | 1999 | 4 | 0.010 |
Why?
| | Oligonucleotides | 1 | 1999 | 4 | 0.010 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 1999 | 9 | 0.010 |
Why?
| | Enzyme Activation | 1 | 1999 | 12 | 0.010 |
Why?
| | Mice, SCID | 1 | 1999 | 13 | 0.010 |
Why?
| | Substrate Specificity | 1 | 1999 | 16 | 0.010 |
Why?
| | Tumor Cells, Cultured | 1 | 1999 | 25 | 0.010 |
Why?
| | Cause of Death | 1 | 1999 | 13 | 0.010 |
Why?
| | Leg | 1 | 1998 | 4 | 0.010 |
Why?
| | Edema | 1 | 1998 | 7 | 0.010 |
Why?
| | Phlebography | 1 | 1998 | 6 | 0.010 |
Why?
| | Vascular Diseases | 1 | 1998 | 7 | 0.010 |
Why?
| | Disease-Free Survival | 1 | 1998 | 45 | 0.010 |
Why?
| | Ligation | 1 | 1998 | 3 | 0.010 |
Why?
| | Internal Fixators | 1 | 1997 | 3 | 0.010 |
Why?
| | Neck Injuries | 1 | 1996 | 1 | 0.010 |
Why?
| | Rib Fractures | 1 | 1996 | 2 | 0.010 |
Why?
| | Lung Injury | 1 | 1996 | 2 | 0.010 |
Why?
| | Glasgow Coma Scale | 1 | 1996 | 6 | 0.010 |
Why?
| | Multiple Trauma | 1 | 1996 | 10 | 0.010 |
Why?
| | Trauma Severity Indices | 1 | 1996 | 13 | 0.010 |
Why?
| | Contusions | 1 | 1996 | 8 | 0.010 |
Why?
| | Accidental Falls | 1 | 1996 | 14 | 0.010 |
Why?
| | Craniocerebral Trauma | 1 | 1996 | 18 | 0.010 |
Why?
| | Fractures, Bone | 1 | 1996 | 34 | 0.010 |
Why?
| | Life Tables | 1 | 1993 | 2 | 0.010 |
Why?
| | Methods | 1 | 1973 | 4 | 0.010 |
Why?
| | Aortography | 1 | 1973 | 2 | 0.010 |
Why?
| | Consciousness | 1 | 1991 | 1 | 0.010 |
Why?
| | Rats, Inbred Strains | 1 | 1991 | 1 | 0.010 |
Why?
| | Cerebrospinal Fluid Shunts | 1 | 1989 | 2 | 0.010 |
Why?
| | Adrenal Cortex Hormones | 1 | 1988 | 36 | 0.000 |
Why?
| | Venous Pressure | 1 | 1987 | 1 | 0.000 |
Why?
|
|
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|